Ravi Mallela
Analyst · Barclays. Please go ahead
Thank you, Adam. We delivered record financial results in the second quarter with strong new business volume, significant growth in our insured portfolio, continued resiliency in our credit performance, and expense efficiency driving record profitability. Net premiums earned were a record $120.9 million, adjusted net income was a record $74.3 million or $0.86 per diluted share, and adjusted return on equity was 19.4%. We generated $16.6 billion of NIW in the second quarter up 17% from the first quarter. Purchase NIW was $16.2 billion during the quarter. Primary insurance in force grew to $168.6 billion, up 6% from the end of the first quarter and up 23%, compared to the second quarter of 2021. 12-month persistency in our primary portfolio improved again reaching 76% compared to 71.5% in the first quarter. We expect persistency will continue to improve meaningfully as we progress through the year, a real positive that will help drive sustained portfolio growth and embedded value gains in the second half. Net premiums earned in the second quarter were $120.9 million compared to $116.5 million in the first quarter. We earned $2.2 million from the cancellation of single premium policies in the second quarter compared to $2.9 million in the first quarter. Reported yield for the second quarter was 30 basis points unchanged from the first quarter. Investment income was $10.9 million in the second quarter compared to $10.2 million in the first quarter. Underwriting and operating expenses were $30.7 million in the second quarter compared to $32.9 million in the first quarter. Our expense ratio was a record low of 25.4% in the quarter highlighting the significant operating leverage embedded in our business and the success we have achieved in efficiently managing our cost base as we have scaled our insured portfolio. We have long signaled our expectation to achieve and sustain a mid-'20s, expense ratio and are proud to be delivering on this guidance. Our credit performance continues to trend in a favorable direction. We had 4,271 defaults in our primary portfolio at June 30, compared to 5,238 at March 31, and our default rate declined to 77 basis points at quarter end. Cure activity during the quarter remained strong and we again released a portion of the reserves we previously established for potential claims outcomes on our early COVID default population, recognizing a $3 million net claims benefit in the second quarter. At the same time, we adopted a more conservative posture for setting reserves across our remaining default population and increased our average carried reserve per default at June 30, in light of the evolving risk environment. Interest expense in the quarter was $8.1 million and we recorded a $1 million gain from the change in the fair value of our warrant liability during the period. All remaining unexercised warrants expired during the second quarter, and as such, we will not see any warrant fair value changes in our financial results in future periods. GAAP net income was a record $75.4 million or $0.86 per diluted share for the quarter, and adjusted net income was a record $74.3 million, also $0.86 per diluted share. Total cash and investments were $2.1 billion at quarter end, including $114 million of cash and investments at the holding company. We have $400 million of outstanding senior notes, in our $250 million revolving credit facility remains undrawn and fully available. In July, Moody's upgraded our financial strength and holding company debt ratings to Baa1 and Ba1 respectively. We're pleased that they recognize the strength of our credit profile, operating performance, financial results, and balance sheet position in their decision. Shareholders' equity as of June 30, was $1.5 billion, and book value per share was $18.01. Book value per share, excluding the impact of net unrealized gains and losses in the investment portfolio was $19.91, up 5% compared to the first quarter and 19% compared to the second quarter of last year. In the second quarter, we repurchased $25 million of our common stock, retiring 1.4 million shares at an average price of $17.61, executing at a level below our book value per share. We have $95 million of repurchase capacity remaining under our existing authorization, and we intend to remain flexible and disciplined in our activity going forward. Balancing the attractive opportunity we see to repurchase the shares at our current valuation against the evolving macroeconomic environment. During the quarter, we entered into a new quota share reinsurance agreement primarily covering the portion of our in-force portfolio that was previously ceded under our first and fourth ILN. We exercised our ability to call these ILNs and reestablished risk protection on the course with the new quota share treaty. The transaction effectively refreshes the coverage we previously had under the retired ILNs on far more efficient terms, providing us with the lower risk attachment point, cheaper cost of capital, and increased PMIERs efficiency. The new quota share agreement is expected to provide an incremental $150 million of PMIERs credit at an estimated 3% weighted average lifetime pre-tax cost of capital. The premium sets on July 1 and it's important to note that it will have a different impact on individual income statement line items than the ILN it replaces. The impact of the new treaty on pre-tax income, effectively its all-in cost is expected to be approximately $1 million per quarter compared to $1.6 million combined for the -- for our first and fourth ILN in their last full quarter's outstanding. The new treaty will, however, have a more significant impact on our ceded premiums, which will be offset by a sizable ceding commission that appears as a benefit to our net operating expenses. Reinsurance remains a core pillar of our credit risk management strategies, providing us with meaningful protection against losses and stress scenarios and an efficient source of growth capital for our business. At quarter end, we reported total available assets under PMIERs of $2.2 billion and risk-based required assets of $1.2 billion. Excess available assets were $929 million, our new quota share reinsurance agreement is not included in these figures as it was completed after quarter end, the new treaty will further bolster our excess position and provide us with even more funding runway and enhanced financial flexibility in future periods. In summary, we achieved record results in Insurance in force, net premiums earned, total revenue, expense ratio, net income, and adjusted net income. Our credit performance continues to stand out in a favorable way. We continue to execute in the reinsurance market on favorable terms and have an exceptionally strong balance sheet. We believe we are well-positioned to continue to perform across all market cycles. With that, let me turn it back to Adam.